NATPARA is a prescription parathyroid hormone used with calcium and vitamin D to control low blood calcium (hypocalcemia) in people with low parathyroid hormone blood levels (hypoparathyroidism).
When will NATPARA be available?
Takeda announced a need for more modifications and testing in addressing capsule problems than initially anticipated in January 2020, affecting its timeline for reintroducing Natpara to U.S. patients. A restoration of treatment availability was reported to be pushed back at least to March 2021.
Who owns NATPARA?
NATPARA.com (the “website”) is owned and operated by Shire Human Genetic Therapies Inc., 300 Shire Way, Lexington, MA 02421 (“Shire Human Genetic Therapies”).
Is NATPARA back on the market?
announced today that we do not expect the NATPARA® (parathyroid hormone) for Injection to return to the US commercial market before March 31, 2022.
How is Hypoparathyroid diagnosed?
A doctor who suspects hypoparathyroidism will take a medical history and conduct a physical exam….These findings on blood tests might indicate hypoparathyroidism:
- A low blood-calcium level.
- A low parathyroid hormone level.
- A high blood-phosphorus level.
- A low blood-magnesium level.
What should I know about Natpara before taking it?
NATPARA can cause some people to have a higher blood calcium level than normal. Your doctor should check your blood calcium before you start and during your treatment with NATPARA. Tell your doctor if you have nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs that you have too much calcium in your blood.
What is Natpara for hypoparathyroidism?
NATPARA for Patients | Hypoparathyroidism Treatment. NATPARA is a prescription parathyroid hormone used with calcium and vitamin D to control low blood calcium (hypocalcemia) in people with low parathyroid hormone blood levels (hypoparathyroidism).
What are the side effects of Natpara cream?
itching rash hives The most common side effects of NATPARA include: tingling, tickling, or burning feeling of the skin, low or high blood calcium, headache, nausea, reduced sense of touch or sensation, diarrhea, vomiting, pain in joints, too much calcium in urine, and pain in limbs.
Does Natpara cause bone cancer?
During animal drug testing, NATPARA caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take NATPARA will have a higher chance of getting osteosarcoma.
